08Jun
FDA Signals a Deliberative Approach to Cannabis at Public Hearing
While it was ostensibly convened to gather scientific input from stakeholders on how to appropriately regulate cannabis-infused products, the Food and Drug Administration (FDA) also used the May 31, 2019 public hearing as a platform to issue a call...
By:
Wilson Sonsini Goodrich & Rosati
Related
In April 2019, the U.S. Department of Labor’s Wage and Hour Division published proposed rules deali...
Read More >
Investments in private companies by way of share purchases from existing shareholders (secondary tra...
Read More >
Reporting Harassment to Third Parties Constitutes Slander - Precedential Decision by Judiciary or R...
Read More >
During the 2020 session, the Florida Legislature enacted a number of provisions intended to ease the...
Read More >
As we move into 2020, there are a number of UK employment law developments on the horizon that requi...
Read More >
On July 29th OSHA submitted a draft Request for Information (RFI) to the Office of Management and Bu...
Read More >